ENZON PHARMACEUTICALS INC
ENZN
ENZN was delisted on the 19th of May, 2016.
2 hedge funds and large institutions have $19.7K invested in ENZON PHARMACEUTICALS INC in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
50% less funds holding
Funds holding: 4 → 2 (-2)
53% less capital invested
Capital invested by funds: $41.7K → $19.7K (-$22K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$18K |
| 2 |
MCM
Monarch Capital Management
Fort Wayne,
Indiana
|
-$4K |
ENZN Hedge Fund Activity: Q4 2016 in Review
2 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q4 2016, worth a combined $19.7K — down 53% from $41.7K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ENZN and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Tudor Investment Corp, exiting entirely with an estimated $18K sold.
- 2 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q4 2016, down from 4 in Q3 2016.
- Funds reported $19.7K of ENZON PHARMACEUTICALS INC stock for Q4 2016, down 53% quarter-over-quarter.
- 0 funds opened new ENZON PHARMACEUTICALS INC positions in Q4 2016 and 2 closed out, a net change of -2 holders.
- The largest ENZON PHARMACEUTICALS INC seller in Q4 2016 was Tudor Investment Corp, an estimated $18K sold.
Based on aggregated 13F filings for Q4 2016.